| Product Code: ETC13144445 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Genomics Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Genomics Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Genomics Market Revenues & Volume, 2021 & 2031F |
3.3 North America Genomics Market - Industry Life Cycle |
3.4 North America Genomics Market - Porter's Five Forces |
3.5 North America Genomics Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Genomics Market Revenues & Volume Share, By Application & Technology, 2021 & 2031F |
3.7 North America Genomics Market Revenues & Volume Share, By Technology Outlook, 2021 & 2031F |
3.8 North America Genomics Market Revenues & Volume Share, By Deliverables, 2021 & 2031F |
3.9 North America Genomics Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 North America Genomics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Genomics Market Trends |
6 North America Genomics Market, 2021 - 2031 |
6.1 North America Genomics Market, Revenues & Volume, By Application & Technology, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Genomics Market, Revenues & Volume, By Functional Genomics, 2021 - 2031 |
6.1.3 North America Genomics Market, Revenues & Volume, By Epigenomics, 2021 - 2031 |
6.1.4 North America Genomics Market, Revenues & Volume, By Pathway Analysis, 2021 - 2031 |
6.1.5 North America Genomics Market, Revenues & Volume, By Biomarker Discovery, 2021 - 2031 |
6.1.6 North America Genomics Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 North America Genomics Market, Revenues & Volume, By Technology Outlook, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Genomics Market, Revenues & Volume, By Sequencing, 2021 - 2031 |
6.2.3 North America Genomics Market, Revenues & Volume, By PCR, 2021 - 2031 |
6.2.4 North America Genomics Market, Revenues & Volume, By Flow Cytometry, 2021 - 2031 |
6.2.5 North America Genomics Market, Revenues & Volume, By Microarrays, 2021 - 2031 |
6.2.6 North America Genomics Market, Revenues & Volume, By Other technologies, 2021 - 2031 |
6.3 North America Genomics Market, Revenues & Volume, By Deliverables, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Genomics Market, Revenues & Volume, By Products, 2021 - 2031 |
6.3.3 North America Genomics Market, Revenues & Volume, By Services, 2021 - 2031 |
6.4 North America Genomics Market, Revenues & Volume, By End-use, 2021 - 2031 |
6.4.2 North America Genomics Market, Revenues & Volume, By Clinical Research, 2021 - 2031 |
6.4.3 North America Genomics Market, Revenues & Volume, By Academic & Government Institutes, 2021 - 2031 |
6.4.4 North America Genomics Market, Revenues & Volume, By Hospitals & Clinics, 2021 - 2031 |
6.4.5 North America Genomics Market, Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021 - 2031 |
6.4.6 North America Genomics Market, Revenues & Volume, By Other End Users, 2021 - 2031 |
7 North America Genomics Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Genomics Market, Revenues & Volume, By Application & Technology, 2021 - 2031 |
7.2.1 United States (US) Genomics Market, Revenues & Volume, By Application & Technology, 2021 - 2031 |
7.2.2 Canada Genomics Market, Revenues & Volume, By Application & Technology, 2021 - 2031 |
7.2.3 Rest of North America Genomics Market, Revenues & Volume, By Application & Technology, 2021 - 2031 |
7.3 North America Genomics Market Revenues & Volume Share, By Technology Outlook, 2021 & 2031F |
7.3.1 United States (US) Genomics Market, Revenues & Volume, By Technology Outlook, 2021 - 2031 |
7.3.2 Canada Genomics Market, Revenues & Volume, By Technology Outlook, 2021 - 2031 |
7.3.3 Rest of North America Genomics Market, Revenues & Volume, By Technology Outlook, 2021 - 2031 |
7.4 North America Genomics Market, Revenues & Volume, By Deliverables, 2021 - 2031 |
7.4.1 United States (US) Genomics Market, Revenues & Volume, By Deliverables, 2021 - 2031 |
7.4.2 Canada Genomics Market, Revenues & Volume, By Deliverables, 2021 - 2031 |
7.4.3 Rest of North America Genomics Market, Revenues & Volume, By Deliverables, 2021 - 2031 |
7.5 North America Genomics Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.5.1 United States (US) Genomics Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.5.2 Canada Genomics Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.5.3 Rest of North America Genomics Market, Revenues & Volume, By End-use, 2021 - 2031 |
8 North America Genomics Market Key Performance Indicators |
9 North America Genomics Market - Export/Import By Countries Assessment |
10 North America Genomics Market - Opportunity Assessment |
10.1 North America Genomics Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Genomics Market Opportunity Assessment, By Application & Technology, 2021 & 2031F |
10.3 North America Genomics Market Opportunity Assessment, By Technology Outlook, 2021 & 2031F |
10.4 North America Genomics Market Opportunity Assessment, By Deliverables, 2021 & 2031F |
10.5 North America Genomics Market Opportunity Assessment, By End-use, 2021 & 2031F |
11 North America Genomics Market - Competitive Landscape |
11.1 North America Genomics Market Revenue Share, By Companies, 2022 |
11.2 North America Genomics Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here